# The Prevent Coronary Artery Disease Trial

> **NCT06494501** · PHASE3 · RECRUITING · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 1600 (estimated)

## Conditions studied

- Atherosclerotic Cardiovascular Disease

## Interventions

- **DRUG:** Inclisiran

## Key facts

- **NCT ID:** NCT06494501
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-12
- **Primary completion:** 2032-06-30
- **Final completion:** 2032-06-30
- **Target enrollment:** 1600 (ESTIMATED)
- **Last updated:** 2025-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06494501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06494501, "The Prevent Coronary Artery Disease Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06494501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*